The global Solid Phase Synthesis Carrier for Peptide Drug market size is predicted to grow from US$ 131 million in 2025 to US$ 231 million in 2031; it is expected to grow at a CAGR of 9.9% from 2025 to 2031.
Compared to liquid-phase synthesis, solid-phase synthesis offers significant advantages, especially in peptide drug production. The solid-phase synthesis carrier immobilizes the starting amino acid, eliminating the need for complex separation and purification steps, thereby greatly enhancing synthesis efficiency. Its ease of operation and repetitive coupling and deprotection steps make it well-suited for automated production, improving manufacturing efficiency and consistency. Furthermore, this method increases the yield and purity of the target product, meeting the growing demands of downstream customers and accelerating the research and industrialization of peptide drugs.
United States market for Solid Phase Synthesis Carrier for Peptide Drug is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Solid Phase Synthesis Carrier for Peptide Drug is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Solid Phase Synthesis Carrier for Peptide Drug is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Solid Phase Synthesis Carrier for Peptide Drug players cover Sunresin, Tianjin Nankai Hecheng Science & Technology, Zhejiang Zhengguang, Jiangsu Haipu Functional Materials, RawPEG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淪olid Phase Synthesis Carrier for Peptide Drug Industry Forecast鈥� looks at past sales and reviews total world Solid Phase Synthesis Carrier for Peptide Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Solid Phase Synthesis Carrier for Peptide Drug sales for 2025 through 2031. With Solid Phase Synthesis Carrier for Peptide Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Solid Phase Synthesis Carrier for Peptide Drug industry.
This Insight Report provides a comprehensive analysis of the global Solid Phase Synthesis Carrier for Peptide Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Solid Phase Synthesis Carrier for Peptide Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Solid Phase Synthesis Carrier for Peptide Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Solid Phase Synthesis Carrier for Peptide Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Solid Phase Synthesis Carrier for Peptide Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Solid Phase Synthesis Carrier for Peptide Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Hydroxyl Resins
Chloromethyl Resins
Amino Resins
Others
Segmentation by Application:
Tumors
Metabolic Diseases
Cardiovascular
Orthopedics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sunresin
Tianjin Nankai Hecheng Science & Technology
Zhejiang Zhengguang
Jiangsu Haipu Functional Materials
RawPEG
Merck
CEM Corporation
Key Questions Addressed in this Report
What is the 10-year outlook for the global Solid Phase Synthesis Carrier for Peptide Drug market?
What factors are driving Solid Phase Synthesis Carrier for Peptide Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Solid Phase Synthesis Carrier for Peptide Drug market opportunities vary by end market size?
How does Solid Phase Synthesis Carrier for Peptide Drug break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Solid Phase Synthesis Carrier for Peptide Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Solid Phase Synthesis Carrier for Peptide Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Solid Phase Synthesis Carrier for Peptide Drug by Country/Region, 2020, 2024 & 2031
2.2 Solid Phase Synthesis Carrier for Peptide Drug Segment by Type
2.2.1 Hydroxyl Resins
2.2.2 Chloromethyl Resins
2.2.3 Amino Resins
2.2.4 Others
2.3 Solid Phase Synthesis Carrier for Peptide Drug Sales by Type
2.3.1 Global Solid Phase Synthesis Carrier for Peptide Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Solid Phase Synthesis Carrier for Peptide Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Solid Phase Synthesis Carrier for Peptide Drug Sale Price by Type (2020-2025)
2.4 Solid Phase Synthesis Carrier for Peptide Drug Segment by Application
2.4.1 Tumors
2.4.2 Metabolic Diseases
2.4.3 Cardiovascular
2.4.4 Orthopedics
2.4.5 Others
2.5 Solid Phase Synthesis Carrier for Peptide Drug Sales by Application
2.5.1 Global Solid Phase Synthesis Carrier for Peptide Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Solid Phase Synthesis Carrier for Peptide Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Solid Phase Synthesis Carrier for Peptide Drug Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Solid Phase Synthesis Carrier for Peptide Drug Breakdown Data by Company
3.1.1 Global Solid Phase Synthesis Carrier for Peptide Drug Annual Sales by Company (2020-2025)
3.1.2 Global Solid Phase Synthesis Carrier for Peptide Drug Sales Market Share by Company (2020-2025)
3.2 Global Solid Phase Synthesis Carrier for Peptide Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Solid Phase Synthesis Carrier for Peptide Drug Revenue by Company (2020-2025)
3.2.2 Global Solid Phase Synthesis Carrier for Peptide Drug Revenue Market Share by Company (2020-2025)
3.3 Global Solid Phase Synthesis Carrier for Peptide Drug Sale Price by Company
3.4 Key Manufacturers Solid Phase Synthesis Carrier for Peptide Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Solid Phase Synthesis Carrier for Peptide Drug Product Location Distribution
3.4.2 Players Solid Phase Synthesis Carrier for Peptide Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Solid Phase Synthesis Carrier for Peptide Drug by Geographic Region
4.1 World Historic Solid Phase Synthesis Carrier for Peptide Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Solid Phase Synthesis Carrier for Peptide Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Solid Phase Synthesis Carrier for Peptide Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Solid Phase Synthesis Carrier for Peptide Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Solid Phase Synthesis Carrier for Peptide Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Solid Phase Synthesis Carrier for Peptide Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Solid Phase Synthesis Carrier for Peptide Drug Sales Growth
4.4 APAC Solid Phase Synthesis Carrier for Peptide Drug Sales Growth
4.5 Europe Solid Phase Synthesis Carrier for Peptide Drug Sales Growth
4.6 Middle East & Africa Solid Phase Synthesis Carrier for Peptide Drug Sales Growth
5 Americas
5.1 Americas Solid Phase Synthesis Carrier for Peptide Drug Sales by Country
5.1.1 Americas Solid Phase Synthesis Carrier for Peptide Drug Sales by Country (2020-2025)
5.1.2 Americas Solid Phase Synthesis Carrier for Peptide Drug Revenue by Country (2020-2025)
5.2 Americas Solid Phase Synthesis Carrier for Peptide Drug Sales by Type (2020-2025)
5.3 Americas Solid Phase Synthesis Carrier for Peptide Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Solid Phase Synthesis Carrier for Peptide Drug Sales by Region
6.1.1 APAC Solid Phase Synthesis Carrier for Peptide Drug Sales by Region (2020-2025)
6.1.2 APAC Solid Phase Synthesis Carrier for Peptide Drug Revenue by Region (2020-2025)
6.2 APAC Solid Phase Synthesis Carrier for Peptide Drug Sales by Type (2020-2025)
6.3 APAC Solid Phase Synthesis Carrier for Peptide Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Solid Phase Synthesis Carrier for Peptide Drug by Country
7.1.1 Europe Solid Phase Synthesis Carrier for Peptide Drug Sales by Country (2020-2025)
7.1.2 Europe Solid Phase Synthesis Carrier for Peptide Drug Revenue by Country (2020-2025)
7.2 Europe Solid Phase Synthesis Carrier for Peptide Drug Sales by Type (2020-2025)
7.3 Europe Solid Phase Synthesis Carrier for Peptide Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Solid Phase Synthesis Carrier for Peptide Drug by Country
8.1.1 Middle East & Africa Solid Phase Synthesis Carrier for Peptide Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Solid Phase Synthesis Carrier for Peptide Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Solid Phase Synthesis Carrier for Peptide Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Solid Phase Synthesis Carrier for Peptide Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Solid Phase Synthesis Carrier for Peptide Drug
10.3 Manufacturing Process Analysis of Solid Phase Synthesis Carrier for Peptide Drug
10.4 Industry Chain Structure of Solid Phase Synthesis Carrier for Peptide Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Solid Phase Synthesis Carrier for Peptide Drug Distributors
11.3 Solid Phase Synthesis Carrier for Peptide Drug Customer
12 World Forecast Review for Solid Phase Synthesis Carrier for Peptide Drug by Geographic Region
12.1 Global Solid Phase Synthesis Carrier for Peptide Drug Market Size Forecast by Region
12.1.1 Global Solid Phase Synthesis Carrier for Peptide Drug Forecast by Region (2026-2031)
12.1.2 Global Solid Phase Synthesis Carrier for Peptide Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Solid Phase Synthesis Carrier for Peptide Drug Forecast by Type (2026-2031)
12.7 Global Solid Phase Synthesis Carrier for Peptide Drug Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Sunresin
13.1.1 Sunresin Company Information
13.1.2 Sunresin Solid Phase Synthesis Carrier for Peptide Drug Product Portfolios and Specifications
13.1.3 Sunresin Solid Phase Synthesis Carrier for Peptide Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sunresin Main Business Overview
13.1.5 Sunresin Latest Developments
13.2 Tianjin Nankai Hecheng Science & Technology
13.2.1 Tianjin Nankai Hecheng Science & Technology Company Information
13.2.2 Tianjin Nankai Hecheng Science & Technology Solid Phase Synthesis Carrier for Peptide Drug Product Portfolios and Specifications
13.2.3 Tianjin Nankai Hecheng Science & Technology Solid Phase Synthesis Carrier for Peptide Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Tianjin Nankai Hecheng Science & Technology Main Business Overview
13.2.5 Tianjin Nankai Hecheng Science & Technology Latest Developments
13.3 Zhejiang Zhengguang
13.3.1 Zhejiang Zhengguang Company Information
13.3.2 Zhejiang Zhengguang Solid Phase Synthesis Carrier for Peptide Drug Product Portfolios and Specifications
13.3.3 Zhejiang Zhengguang Solid Phase Synthesis Carrier for Peptide Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Zhejiang Zhengguang Main Business Overview
13.3.5 Zhejiang Zhengguang Latest Developments
13.4 Jiangsu Haipu Functional Materials
13.4.1 Jiangsu Haipu Functional Materials Company Information
13.4.2 Jiangsu Haipu Functional Materials Solid Phase Synthesis Carrier for Peptide Drug Product Portfolios and Specifications
13.4.3 Jiangsu Haipu Functional Materials Solid Phase Synthesis Carrier for Peptide Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Jiangsu Haipu Functional Materials Main Business Overview
13.4.5 Jiangsu Haipu Functional Materials Latest Developments
13.5 RawPEG
13.5.1 RawPEG Company Information
13.5.2 RawPEG Solid Phase Synthesis Carrier for Peptide Drug Product Portfolios and Specifications
13.5.3 RawPEG Solid Phase Synthesis Carrier for Peptide Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 RawPEG Main Business Overview
13.5.5 RawPEG Latest Developments
13.6 Merck
13.6.1 Merck Company Information
13.6.2 Merck Solid Phase Synthesis Carrier for Peptide Drug Product Portfolios and Specifications
13.6.3 Merck Solid Phase Synthesis Carrier for Peptide Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Merck Main Business Overview
13.6.5 Merck Latest Developments
13.7 CEM Corporation
13.7.1 CEM Corporation Company Information
13.7.2 CEM Corporation Solid Phase Synthesis Carrier for Peptide Drug Product Portfolios and Specifications
13.7.3 CEM Corporation Solid Phase Synthesis Carrier for Peptide Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 CEM Corporation Main Business Overview
13.7.5 CEM Corporation Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
